ID   TOP2_YEAST              Reviewed;        1428 AA.
AC   P06786; D6W191;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   22-JUL-2015, entry version 181.
DE   RecName: Full=DNA topoisomerase 2;
DE            EC=5.99.1.3;
DE   AltName: Full=DNA topoisomerase II;
GN   Name=TOP2; Synonyms=TOR3; OrderedLocusNames=YNL088W; ORFNames=N2244;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3017975;
RA   Giaever F., Lynn R., Goto T., Wang J.C.;
RT   "The complete nucleotide sequence of the structural gene TOP2 of yeast
RT   DNA topoisomerase II.";
RL   J. Biol. Chem. 261:12448-12454(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=S96, YJM 320, and YJM 326;
RX   PubMed=11907579; DOI=10.1038/416326a;
RA   Steinmetz L.M., Sinha H., Richards D.R., Spiegelman J.I., Oefner P.J.,
RA   McCusker J.H., Davis R.W.;
RT   "Dissecting the architecture of a quantitative trait locus in yeast.";
RL   Nature 416:326-330(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 96604 / S288c / FY1679;
RX   PubMed=8740422;
RX   DOI=10.1002/(SICI)1097-0061(199604)12:5<485::AID-YEA928>3.0.CO;2-U;
RA   Soler-Mira A., Saiz J.E., Ballesta J.P.G., Remacha M.A.;
RT   "The sequence of a 17,933 bp segment of Saccharomyces cerevisiae
RT   chromosome XIV contains the RHO2, TOP2, MKT1 and END3 genes and five
RT   new open reading frames.";
RL   Yeast 12:485-491(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169873;
RA   Philippsen P., Kleine K., Poehlmann R., Duesterhoeft A., Hamberg K.,
RA   Hegemann J.H., Obermaier B., Urrestarazu L.A., Aert R., Albermann K.,
RA   Altmann R., Andre B., Baladron V., Ballesta J.P.G., Becam A.-M.,
RA   Beinhauer J.D., Boskovic J., Buitrago M.J., Bussereau F., Coster F.,
RA   Crouzet M., D'Angelo M., Dal Pero F., De Antoni A., del Rey F.,
RA   Doignon F., Domdey H., Dubois E., Fiedler T.A., Fleig U., Floeth M.,
RA   Fritz C., Gaillardin C., Garcia-Cantalejo J.M., Glansdorff N.,
RA   Goffeau A., Gueldener U., Herbert C.J., Heumann K., Heuss-Neitzel D.,
RA   Hilbert H., Hinni K., Iraqui Houssaini I., Jacquet M., Jimenez A.,
RA   Jonniaux J.-L., Karpfinger-Hartl L., Lanfranchi G., Lepingle A.,
RA   Levesque H., Lyck R., Maftahi M., Mallet L., Maurer C.T.C.,
RA   Messenguy F., Mewes H.-W., Moestl D., Nasr F., Nicaud J.-M.,
RA   Niedenthal R.K., Pandolfo D., Pierard A., Piravandi E., Planta R.J.,
RA   Pohl T.M., Purnelle B., Rebischung C., Remacha M.A., Revuelta J.L.,
RA   Rinke M., Saiz J.E., Sartorello F., Scherens B., Sen-Gupta M.,
RA   Soler-Mira A., Urbanus J.H.M., Valle G., Van Dyck L., Verhasselt P.,
RA   Vierendeels F., Vissers S., Voet M., Volckaert G., Wach A.,
RA   Wambutt R., Wedler H., Zollner A., Hani J.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XIV
RT   and its evolutionary implications.";
RL   Nature 387:93-98(1997).
RN   [5]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [6]
RP   REVIEW ON PHOSPHORYLATION.
RX   PubMed=1332607; DOI=10.1007/BF00584459;
RA   Gasser S.M., Walter R., Dang Q., Cardenas M.E.;
RT   "Topoisomerase II: its functions and phosphorylation.";
RL   Antonie Van Leeuwenhoek 62:15-24(1992).
RN   [7]
RP   PHOSPHORYLATION AT THR-1086; SER-1087; THR-1258; SER-1266; SER-1269;
RP   SER-1272; SER-1353; SER-1356; SER-1408 AND SER-1423.
RX   PubMed=1316274;
RA   Cardenas M.E., Dang Q., Glover C.V., Gasser S.M.;
RT   "Casein kinase II phosphorylates the eukaryote-specific C-terminal
RT   domain of topoisomerase II in vivo.";
RL   EMBO J. 11:1785-1796(1992).
RN   [8]
RP   SUBUNIT, ACTIVE SITE, CATALYTIC ACTIVITY, FUNCTION, AND MUTAGENESIS OF
RP   ARG-690; ASP-697; LYS-700; ARG-704; HIS-736; ARG-781; TYR-782 AND
RP   ASN-828.
RX   PubMed=9685374; DOI=10.1074/jbc.273.32.20252;
RA   Liu Q., Wang J.C.;
RT   "Identification of active site residues in the 'GyrA' half of yeast
RT   DNA topoisomerase II.";
RL   J. Biol. Chem. 273:20252-20260(1998).
RN   [9]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A.,
RA   Dephoure N., O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ADR376;
RX   PubMed=17330950; DOI=10.1021/pr060559j;
RA   Li X., Gerber S.A., Rudner A.D., Beausoleil S.A., Haas W., Villen J.,
RA   Elias J.E., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of alpha-factor-arrested
RT   Saccharomyces cerevisiae.";
RL   J. Proteome Res. 6:1190-1197(2007).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.M700468-MCP200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth
RT   phosphoproteome analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1252, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19779198; DOI=10.1126/science.1172867;
RA   Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.;
RT   "Global analysis of Cdk1 substrate phosphorylation sites provides
RT   insights into evolution.";
RL   Science 325:1682-1686(2009).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 410-1202.
RX   PubMed=8538787; DOI=10.1038/379225a0;
RA   Berger J.M., Gamblin S.J., Harrison S.C., Wang J.C.;
RT   "Structure and mechanism of DNA topoisomerase II.";
RL   Nature 379:225-232(1996).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 409-1201.
RX   PubMed=10201398; DOI=10.1038/7556;
RA   Fass D., Bogden C.E., Berger J.M.;
RT   "Quaternary changes in topoisomerase II may direct orthogonal movement
RT   of two DNA strands.";
RL   Nat. Struct. Biol. 6:322-326(1999).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1-413 IN COMPLEX WITH ATP
RP   ANALOG, AND SUBUNIT.
RX   PubMed=12963818; DOI=10.1073/pnas.1832879100;
RA   Classen S., Olland S., Berger J.M.;
RT   "Structure of the topoisomerase II ATPase region and its mechanism of
RT   inhibition by the chemotherapeutic agent ICRF-187.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:10629-10634(2003).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 419-1177 IN COMPLEX WITH DNA
RP   AND MAGNESIUM, CATALYTIC ACTIVITY, AND COFACTOR.
RX   PubMed=18097402; DOI=10.1038/nature06396;
RA   Dong K.C., Berger J.M.;
RT   "Structural basis for gate-DNA recognition and bending by type IIA
RT   topoisomerases.";
RL   Nature 450:1201-1205(2007).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.48 ANGSTROMS) OF 421-1177 IN COMPLEX WITH DNA
RP   AND ZINC IONS, ACTIVE SITE, ENZYME MECHANISM, AND COFACTOR.
RX   PubMed=20485342; DOI=10.1038/nature08974;
RA   Schmidt B.H., Burgin A.B., Deweese J.E., Osheroff N., Berger J.M.;
RT   "A novel and unified two-metal mechanism for DNA cleavage by type II
RT   and IA topoisomerases.";
RL   Nature 465:641-644(2010).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (4.4 ANGSTROMS) OF 1-1177 IN COMPLEX WITH DNA
RP   AND ATP ANALOG, CATALYTIC ACTIVITY, FUNCTION, AND SUBUNIT.
RX   PubMed=23022727; DOI=10.1038/nsmb.2388;
RA   Schmidt B.H., Osheroff N., Berger J.M.;
RT   "Structure of a topoisomerase II-DNA-nucleotide complex reveals a new
RT   control mechanism for ATPase activity.";
RL   Nat. Struct. Mol. Biol. 19:1147-1154(2012).
CC   -!- FUNCTION: Control of topological states of DNA by transient
CC       breakage and subsequent rejoining of DNA strands. Topoisomerase II
CC       makes double-strand breaks. Essential during mitosis and meiosis
CC       for proper segregation of daughter chromosomes.
CC       {ECO:0000269|PubMed:23022727, ECO:0000269|PubMed:9685374}.
CC   -!- CATALYTIC ACTIVITY: ATP-dependent breakage, passage and rejoining
CC       of double-stranded DNA. {ECO:0000255|PROSITE-ProRule:PRU00995,
CC       ECO:0000269|PubMed:18097402, ECO:0000269|PubMed:23022727,
CC       ECO:0000269|PubMed:9685374}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00995,
CC         ECO:0000269|PubMed:18097402, ECO:0000269|PubMed:20485342};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00995,
CC         ECO:0000269|PubMed:18097402, ECO:0000269|PubMed:20485342};
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00995,
CC         ECO:0000269|PubMed:18097402, ECO:0000269|PubMed:20485342};
CC       Note=Binds two Mg(2+) per subunit. The magnesium ions form salt
CC       bridges with both the protein and the DNA. Can also accept other
CC       divalent metal cations, such as Mn(2+) or Ca(2+).
CC       {ECO:0000255|PROSITE-ProRule:PRU00995,
CC       ECO:0000269|PubMed:18097402, ECO:0000269|PubMed:20485342};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:12963818,
CC       ECO:0000269|PubMed:18097402, ECO:0000269|PubMed:20485342,
CC       ECO:0000269|PubMed:23022727, ECO:0000269|PubMed:9685374}.
CC   -!- INTERACTION:
CC       P24583:PKC1; NbExp=2; IntAct=EBI-19352, EBI-9860;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- PTM: Phosphorylation enhances the activity. Stimulates
CC       decatenation activity. {ECO:0000269|PubMed:1316274}.
CC   -!- MISCELLANEOUS: In yeast topoisomerase II can substitute
CC       topoisomerase I for the relaxing activity.
CC   -!- MISCELLANEOUS: Eukaryotic topoisomerase I and II can relax both
CC       negative and positive supercoils, whereas prokaryotic enzymes
CC       relax only negative supercoils.
CC   -!- MISCELLANEOUS: Present with 5730 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the type II topoisomerase family.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Toprim domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00995}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M13814; AAB36610.1; -; Genomic_DNA.
DR   EMBL; AF458969; AAM00518.1; -; Genomic_DNA.
DR   EMBL; AF458971; AAM00530.1; -; Genomic_DNA.
DR   EMBL; AF458972; AAM00536.1; -; Genomic_DNA.
DR   EMBL; X89016; CAA61422.1; -; Genomic_DNA.
DR   EMBL; Z71364; CAA95964.1; -; Genomic_DNA.
DR   EMBL; BK006947; DAA10457.1; -; Genomic_DNA.
DR   PIR; S57534; ISBYT2.
DR   RefSeq; NP_014311.3; NM_001182926.3.
DR   PDB; 1BGW; X-ray; 2.70 A; A=409-1201.
DR   PDB; 1BJT; X-ray; 2.50 A; A=409-1201.
DR   PDB; 1PVG; X-ray; 1.80 A; A/B=1-413.
DR   PDB; 1QZR; X-ray; 1.90 A; A/B=1-413.
DR   PDB; 2RGR; X-ray; 3.00 A; A=419-1177.
DR   PDB; 3L4J; X-ray; 2.48 A; A=421-1177.
DR   PDB; 3L4K; X-ray; 2.98 A; A=421-1177.
DR   PDB; 4GFH; X-ray; 4.41 A; A/F=1-1177.
DR   PDBsum; 1BGW; -.
DR   PDBsum; 1BJT; -.
DR   PDBsum; 1PVG; -.
DR   PDBsum; 1QZR; -.
DR   PDBsum; 2RGR; -.
DR   PDBsum; 3L4J; -.
DR   PDBsum; 3L4K; -.
DR   PDBsum; 4GFH; -.
DR   DisProt; DP00076; -.
DR   ProteinModelPortal; P06786; -.
DR   SMR; P06786; 8-405, 419-1177.
DR   BioGrid; 35735; 76.
DR   DIP; DIP-2300N; -.
DR   IntAct; P06786; 19.
DR   MINT; MINT-495862; -.
DR   ChEMBL; CHEMBL5290; -.
DR   MaxQB; P06786; -.
DR   PaxDb; P06786; -.
DR   PeptideAtlas; P06786; -.
DR   EnsemblFungi; YNL088W; YNL088W; YNL088W.
DR   GeneID; 855636; -.
DR   KEGG; sce:YNL088W; -.
DR   CYGD; YNL088w; -.
DR   EuPathDB; FungiDB:YNL088W; -.
DR   SGD; S000005032; TOP2.
DR   eggNOG; COG0187; -.
DR   GeneTree; ENSGT00390000016222; -.
DR   HOGENOM; HOG000216693; -.
DR   InParanoid; P06786; -.
DR   KO; K03164; -.
DR   OMA; TCSPDPR; -.
DR   OrthoDB; EOG7CCC0D; -.
DR   BioCyc; YEAST:G3O-33117-MONOMER; -.
DR   BRENDA; 5.99.1.3; 984.
DR   EvolutionaryTrace; P06786; -.
DR   NextBio; 979854; -.
DR   PRO; PR:P06786; -.
DR   Proteomes; UP000002311; Chromosome XIV.
DR   GO; GO:0097047; C:DNA replication termination region; IPI:SGD.
DR   GO; GO:0005634; C:nucleus; IDA:SGD.
DR   GO; GO:0000795; C:synaptonemal complex; IDA:SGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003918; F:DNA topoisomerase type II (ATP-hydrolyzing) activity; IDA:SGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006333; P:chromatin assembly or disassembly; IMP:SGD.
DR   GO; GO:0031055; P:chromatin remodeling at centromere; IMP:SGD.
DR   GO; GO:0006271; P:DNA strand elongation involved in DNA replication; IMP:SGD.
DR   GO; GO:0006265; P:DNA topological change; IDA:SGD.
DR   GO; GO:0006268; P:DNA unwinding involved in DNA replication; IMP:SGD.
DR   GO; GO:0044774; P:mitotic DNA integrity checkpoint; IMP:SGD.
DR   GO; GO:0007131; P:reciprocal meiotic recombination; IMP:SGD.
DR   GO; GO:0000019; P:regulation of mitotic recombination; IMP:SGD.
DR   GO; GO:0097046; P:replication fork progression beyond termination site; IMP:SGD.
DR   Gene3D; 1.10.268.10; -; 1.
DR   Gene3D; 3.30.1360.40; -; 1.
DR   Gene3D; 3.30.230.10; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   Gene3D; 3.40.50.670; -; 1.
DR   Gene3D; 3.90.199.10; -; 2.
DR   InterPro; IPR024946; Arg_repress_C-like.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   InterPro; IPR014721; Ribosomal_S5_D2-typ_fold_subgr.
DR   InterPro; IPR001241; Topo_IIA.
DR   InterPro; IPR013760; Topo_IIA-like_dom.
DR   InterPro; IPR002205; Topo_IIA_A/C.
DR   InterPro; IPR013758; Topo_IIA_A/C_ab.
DR   InterPro; IPR013757; Topo_IIA_A_a.
DR   InterPro; IPR013506; Topo_IIA_bsu_dom2.
DR   InterPro; IPR013759; Topo_IIA_cen_dom.
DR   InterPro; IPR018522; TopoIIA_CS.
DR   InterPro; IPR006171; Toprim_domain.
DR   Pfam; PF00204; DNA_gyraseB; 1.
DR   Pfam; PF00521; DNA_topoisoIV; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF01751; Toprim; 1.
DR   PRINTS; PR00418; TPI2FAMILY.
DR   SMART; SM00387; HATPase_c; 1.
DR   SMART; SM00433; TOP2c; 1.
DR   SMART; SM00434; TOP4c; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   SUPFAM; SSF56719; SSF56719; 1.
DR   PROSITE; PS00177; TOPOISOMERASE_II; 1.
DR   PROSITE; PS50880; TOPRIM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; DNA-binding; Isomerase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Topoisomerase.
FT   CHAIN         1   1428       DNA topoisomerase 2.
FT                                /FTId=PRO_0000145387.
FT   DOMAIN      443    557       Toprim. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00995}.
FT   NP_BIND     127    129       ATP.
FT   NP_BIND     140    147       ATP.
FT   NP_BIND     365    367       ATP.
FT   REGION      333    336       Interaction with DNA.
FT   REGION      965    974       Interaction with DNA.
FT   ACT_SITE    782    782       O-(5'-phospho-DNA)-tyrosine intermediate.
FT                                {ECO:0000269|PubMed:20485342,
FT                                ECO:0000269|PubMed:9685374}.
FT   METAL       449    449       Magnesium 1; catalytic.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00995,
FT                                ECO:0000269|PubMed:18097402}.
FT   METAL       526    526       Magnesium 1; catalytic.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00995,
FT                                ECO:0000269|PubMed:18097402}.
FT   METAL       526    526       Magnesium 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00995,
FT                                ECO:0000269|PubMed:18097402}.
FT   METAL       528    528       Magnesium 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00995,
FT                                ECO:0000269|PubMed:18097402}.
FT   BINDING      70     70       ATP.
FT   BINDING      99     99       ATP.
FT   SITE        477    477       Interaction with DNA.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00995}.
FT   SITE        480    480       Interaction with DNA.
FT   SITE        650    650       Interaction with DNA.
FT   SITE        651    651       Interaction with DNA.
FT   SITE        700    700       Interaction with DNA.
FT   SITE        734    734       Interaction with DNA.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00995}.
FT   SITE        740    740       Interaction with DNA.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00995}.
FT   SITE        781    781       Transition state stabilizer.
FT   SITE        833    833       Important for DNA bending; intercalates
FT                                between base pairs of target DNA.
FT   SITE        908    908       Interaction with DNA.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00995}.
FT   MOD_RES    1086   1086       Phosphothreonine; by CK2.
FT                                {ECO:0000269|PubMed:1316274}.
FT   MOD_RES    1087   1087       Phosphoserine; by CK2.
FT                                {ECO:0000269|PubMed:1316274}.
FT   MOD_RES    1252   1252       Phosphoserine.
FT                                {ECO:0000269|PubMed:19779198}.
FT   MOD_RES    1258   1258       Phosphothreonine; by CK2.
FT                                {ECO:0000269|PubMed:1316274}.
FT   MOD_RES    1266   1266       Phosphoserine; by CK2.
FT                                {ECO:0000269|PubMed:1316274}.
FT   MOD_RES    1269   1269       Phosphoserine; by CK2.
FT                                {ECO:0000269|PubMed:1316274}.
FT   MOD_RES    1272   1272       Phosphoserine; by CK2.
FT                                {ECO:0000269|PubMed:1316274}.
FT   MOD_RES    1353   1353       Phosphoserine; by CK2.
FT                                {ECO:0000269|PubMed:1316274}.
FT   MOD_RES    1356   1356       Phosphoserine; by CK2.
FT                                {ECO:0000269|PubMed:1316274}.
FT   MOD_RES    1408   1408       Phosphoserine; by CK2.
FT                                {ECO:0000269|PubMed:1316274}.
FT   MOD_RES    1423   1423       Phosphoserine; by CK2.
FT                                {ECO:0000269|PubMed:1316274}.
FT   MUTAGEN     333    336       KKKK->AAAA: Reduced enzyme activity;
FT                                abolishes stimulation of ATPase activity
FT                                upon DNA binding.
FT   MUTAGEN     333    336       KKKK->AEEA: Strongly reduced enzyme
FT                                activity; abolishes stimulation of ATPase
FT                                activity upon DNA binding.
FT   MUTAGEN     690    690       R->A: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:9685374}.
FT   MUTAGEN     697    697       D->A: Strongly reduced enzyme activity.
FT                                {ECO:0000269|PubMed:9685374}.
FT   MUTAGEN     700    700       K->A: Strongly reduced enzyme activity.
FT                                {ECO:0000269|PubMed:9685374}.
FT   MUTAGEN     704    704       R->A: Strongly reduced enzyme activity.
FT                                {ECO:0000269|PubMed:9685374}.
FT   MUTAGEN     736    736       H->A: No effect.
FT                                {ECO:0000269|PubMed:9685374}.
FT   MUTAGEN     781    781       R->A: Strongly reduced enzyme activity.
FT                                {ECO:0000269|PubMed:9685374}.
FT   MUTAGEN     782    782       Y->F: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:9685374}.
FT   MUTAGEN     828    828       N->A: Strongly reduced enzyme activity.
FT                                {ECO:0000269|PubMed:9685374}.
FT   CONFLICT     74     74       N -> NN (in Ref. 1; AAB36610).
FT                                {ECO:0000305}.
FT   CONFLICT    547    547       P -> L (in Ref. 1; AAB36610).
FT                                {ECO:0000305}.
FT   CONFLICT    837    837       W -> R (in Ref. 1; AAB36610).
FT                                {ECO:0000305}.
FT   HELIX         8     11       {ECO:0000244|PDB:1PVG}.
FT   STRAND       12     14       {ECO:0000244|PDB:1PVG}.
FT   HELIX        17     23       {ECO:0000244|PDB:1PVG}.
FT   HELIX        26     29       {ECO:0000244|PDB:1PVG}.
FT   STRAND       35     43       {ECO:0000244|PDB:1PVG}.
FT   TURN         44     47       {ECO:0000244|PDB:1PVG}.
FT   STRAND       48     56       {ECO:0000244|PDB:1PVG}.
FT   HELIX        58     77       {ECO:0000244|PDB:1PVG}.
FT   STRAND       83     89       {ECO:0000244|PDB:1PVG}.
FT   TURN         90     93       {ECO:0000244|PDB:1PVG}.
FT   STRAND       94    102       {ECO:0000244|PDB:1PVG}.
FT   TURN        110    112       {ECO:0000244|PDB:1PVG}.
FT   HELIX       116    122       {ECO:0000244|PDB:1PVG}.
FT   STRAND      123    128       {ECO:0000244|PDB:1PVG}.
FT   HELIX       145    151       {ECO:0000244|PDB:1PVG}.
FT   STRAND      153    162       {ECO:0000244|PDB:1PVG}.
FT   TURN        163    166       {ECO:0000244|PDB:1PVG}.
FT   STRAND      167    174       {ECO:0000244|PDB:1PVG}.
FT   TURN        175    178       {ECO:0000244|PDB:1PVG}.
FT   STRAND      184    187       {ECO:0000244|PDB:1PVG}.
FT   STRAND      194    201       {ECO:0000244|PDB:1PVG}.
FT   HELIX       203    206       {ECO:0000244|PDB:1PVG}.
FT   HELIX       213    229       {ECO:0000244|PDB:1PVG}.
FT   STRAND      234    237       {ECO:0000244|PDB:1PVG}.
FT   HELIX       247    252       {ECO:0000244|PDB:1PVG}.
FT   TURN        253    257       {ECO:0000244|PDB:1PVG}.
FT   STRAND      280    285       {ECO:0000244|PDB:1PVG}.
FT   STRAND      288    294       {ECO:0000244|PDB:1PVG}.
FT   STRAND      296    298       {ECO:0000244|PDB:1PVG}.
FT   STRAND      300    305       {ECO:0000244|PDB:1PVG}.
FT   HELIX       315    332       {ECO:0000244|PDB:1PVG}.
FT   HELIX       342    346       {ECO:0000244|PDB:1PVG}.
FT   STRAND      349    355       {ECO:0000244|PDB:1PVG}.
FT   STRAND      362    364       {ECO:0000244|PDB:1PVG}.
FT   HELIX       374    376       {ECO:0000244|PDB:1PVG}.
FT   STRAND      377    379       {ECO:0000244|PDB:1PVG}.
FT   HELIX       385    391       {ECO:0000244|PDB:1PVG}.
FT   HELIX       395    405       {ECO:0000244|PDB:1PVG}.
FT   TURN        433    436       {ECO:0000244|PDB:1BJT}.
FT   HELIX       438    442       {ECO:0000244|PDB:1BJT}.
FT   STRAND      444    450       {ECO:0000244|PDB:1BJT}.
FT   HELIX       451    464       {ECO:0000244|PDB:1BJT}.
FT   STRAND      466    475       {ECO:0000244|PDB:1BJT}.
FT   STRAND      479    481       {ECO:0000244|PDB:1BGW}.
FT   HELIX       486    491       {ECO:0000244|PDB:2RGR}.
FT   HELIX       492    502       {ECO:0000244|PDB:1BJT}.
FT   TURN        503    505       {ECO:0000244|PDB:1BGW}.
FT   STRAND      506    508       {ECO:0000244|PDB:1BJT}.
FT   STRAND      513    517       {ECO:0000244|PDB:1BJT}.
FT   STRAND      519    525       {ECO:0000244|PDB:1BJT}.
FT   STRAND      527    530       {ECO:0000244|PDB:1BGW}.
FT   HELIX       534    545       {ECO:0000244|PDB:1BJT}.
FT   HELIX       547    550       {ECO:0000244|PDB:1BGW}.
FT   STRAND      555    558       {ECO:0000244|PDB:1BJT}.
FT   STRAND      563    568       {ECO:0000244|PDB:1BJT}.
FT   STRAND      574    580       {ECO:0000244|PDB:1BJT}.
FT   HELIX       581    590       {ECO:0000244|PDB:1BJT}.
FT   TURN        591    594       {ECO:0000244|PDB:1BJT}.
FT   STRAND      597    599       {ECO:0000244|PDB:1BJT}.
FT   HELIX       609    629       {ECO:0000244|PDB:1BJT}.
FT   HELIX       634    642       {ECO:0000244|PDB:2RGR}.
FT   HELIX       647    656       {ECO:0000244|PDB:2RGR}.
FT   STRAND      668    670       {ECO:0000244|PDB:2RGR}.
FT   HELIX       678    691       {ECO:0000244|PDB:1BJT}.
FT   TURN        695    697       {ECO:0000244|PDB:1BJT}.
FT   HELIX       701    713       {ECO:0000244|PDB:1BJT}.
FT   HELIX       721    732       {ECO:0000244|PDB:1BJT}.
FT   STRAND      736    738       {ECO:0000244|PDB:1BJT}.
FT   HELIX       741    749       {ECO:0000244|PDB:1BJT}.
FT   TURN        753    755       {ECO:0000244|PDB:2RGR}.
FT   STRAND      760    765       {ECO:0000244|PDB:1BJT}.
FT   TURN        770    773       {ECO:0000244|PDB:1BJT}.
FT   TURN        780    782       {ECO:0000244|PDB:1BJT}.
FT   STRAND      784    787       {ECO:0000244|PDB:1BJT}.
FT   HELIX       791    794       {ECO:0000244|PDB:1BJT}.
FT   HELIX       797    802       {ECO:0000244|PDB:1BJT}.
FT   STRAND      805    808       {ECO:0000244|PDB:1BJT}.
FT   STRAND      811    816       {ECO:0000244|PDB:1BJT}.
FT   HELIX       824    827       {ECO:0000244|PDB:1BJT}.
FT   STRAND      830    833       {ECO:0000244|PDB:1BJT}.
FT   STRAND      838    841       {ECO:0000244|PDB:1BJT}.
FT   HELIX       846    857       {ECO:0000244|PDB:1BJT}.
FT   STRAND      874    880       {ECO:0000244|PDB:1BJT}.
FT   STRAND      883    887       {ECO:0000244|PDB:1BJT}.
FT   STRAND      889    894       {ECO:0000244|PDB:1BJT}.
FT   STRAND      897    902       {ECO:0000244|PDB:1BJT}.
FT   HELIX       909    920       {ECO:0000244|PDB:1BJT}.
FT   STRAND      924    926       {ECO:0000244|PDB:1BGW}.
FT   STRAND      932    935       {ECO:0000244|PDB:1BJT}.
FT   STRAND      938    940       {ECO:0000244|PDB:1BJT}.
FT   STRAND      943    946       {ECO:0000244|PDB:1BJT}.
FT   HELIX       949    958       {ECO:0000244|PDB:1BJT}.
FT   HELIX       960    963       {ECO:0000244|PDB:1BJT}.
FT   STRAND      967    971       {ECO:0000244|PDB:1BJT}.
FT   STRAND      975    978       {ECO:0000244|PDB:1BJT}.
FT   STRAND      984    989       {ECO:0000244|PDB:1BJT}.
FT   HELIX       990   1034       {ECO:0000244|PDB:1BJT}.
FT   STRAND     1041   1043       {ECO:0000244|PDB:1BGW}.
FT   HELIX      1045   1054       {ECO:0000244|PDB:1BJT}.
FT   TURN       1108   1110       {ECO:0000244|PDB:1BJT}.
FT   HELIX      1114   1117       {ECO:0000244|PDB:1BJT}.
FT   HELIX      1121   1124       {ECO:0000244|PDB:1BJT}.
FT   HELIX      1126   1147       {ECO:0000244|PDB:1BJT}.
FT   HELIX      1151   1176       {ECO:0000244|PDB:1BJT}.
SQ   SEQUENCE   1428 AA;  164215 MW;  0E29EB8B89AA1387 CRC64;
     MSTEPVSASD KYQKISQLEH ILKRPDTYIG SVETQEQLQW IYDEETDCMI EKNVTIVPGL
     FKIFDEILVN AADNKVRDPS MKRIDVNIHA EEHTIEVKND GKGIPIEIHN KENIYIPEMI
     FGHLLTSSNY DDDEKKVTGG RNGYGAKLCN IFSTEFILET ADLNVGQKYV QKWENNMSIC
     HPPKITSYKK GPSYTKVTFK PDLTRFGMKE LDNDILGVMR RRVYDINGSV RDINVYLNGK
     SLKIRNFKNY VELYLKSLEK KRQLDNGEDG AAKSDIPTIL YERINNRWEV AFAVSDISFQ
     QISFVNSIAT TMGGTHVNYI TDQIVKKISE ILKKKKKKSV KSFQIKNNMF IFINCLIENP
     AFTSQTKEQL TTRVKDFGSR CEIPLEYINK IMKTDLATRM FEIADANEEN ALKKSDGTRK
     SRITNYPKLE DANKAGTKEG YKCTLVLTEG DSALSLAVAG LAVVGRDYYG CYPLRGKMLN
     VREASADQIL KNAEIQAIKK IMGLQHRKKY EDTKSLRYGH LMIMTDQDHD GSHIKGLIIN
     FLESSFPGLL DIQGFLLEFI TPIIKVSITK PTKNTIAFYN MPDYEKWREE ESHKFTWKQK
     YYKGLGTSLA QEVREYFSNL DRHLKIFHSL QGNDKDYIDL AFSKKKADDR KEWLRQYEPG
     TVLDPTLKEI PISDFINKEL ILFSLADNIR SIPNVLDGFK PGQRKVLYGC FKKNLKSELK
     VAQLAPYVSE CTAYHHGEQS LAQTIIGLAQ NFVGSNNIYL LLPNGAFGTR ATGGKDAAAA
     RYIYTELNKL TRKIFHPADD PLYKYIQEDE KTVEPEWYLP ILPMILVNGA EGIGTGWSTY
     IPPFNPLEII KNIRHLMNDE ELEQMHPWFR GWTGTIEEIE PLRYRMYGRI EQIGDNVLEI
     TELPARTWTS TIKEYLLLGL SGNDKIKPWI KDMEEQHDDN IKFIITLSPE EMAKTRKIGF
     YERFKLISPI SLMNMVAFDP HGKIKKYNSV NEILSEFYYV RLEYYQKRKD HMSERLQWEV
     EKYSFQVKFI KMIIEKELTV TNKPRNAIIQ ELENLGFPRF NKEGKPYYGS PNDEIAEQIN
     DVKGATSDEE DEESSHEDTE NVINGPEELY GTYEYLLGMR IWSLTKERYQ KLLKQKQEKE
     TELENLLKLS AKDIWNTDLK AFEVGYQEFL QRDAEARGGN VPNKGSKTKG KGKRKLVDDE
     DYDPSKKNKK STARKGKKIK LEDKNFERIL LEQKLVTKSK APTKIKKEKT PSVSETKTEE
     EENAPSSTSS SSIFDIKKED KDEGELSKIS NKFKKISTIF DKMGSTSATS KENTPEQDDV
     ATKKNQTTAK KTAVKPKLAK KPVRKQQKVV ELSGESDLEI LDSYTDREDS NKDEDDAIPQ
     RSRRQRSSRA ASVPKKSYVE TLELSDDSFI EDDEEENQGS DVSFNEED
//
